IACTA Pharmaceuticals Announces Expansion of Scientific Advisory Board with Two World-Renowned Key Opinion Leaders
IACTA Pharmaceuticals, Inc. ("IACTA"), an innovation leader in ophthalmic therapeutics, today announced the expansion of its Scientific Advisory Board (SAB) with the appointments of Dr. Richard L. Abbott and Dr. Lixin Xie.
- IACTA Pharmaceuticals, Inc. ("IACTA"), an innovation leader in ophthalmic therapeutics, today announced the expansion of its Scientific Advisory Board (SAB) with the appointments of Dr. Richard L. Abbott and Dr. Lixin Xie.
- "I look forward to collaborating with the team on the edge of innovative discoveries in the ocular market for patients with unmet needs."
- "I am pleased to join the Scientific Advisory Board at IACTA, a company committed to pioneering research in ocular diseases," said Professor Xie.
- IACTA is a registered trademark of Iacta Pharmaceuticals, Inc., and DENKI is a trademark licensed to Iacta Pharmaceuticals, Inc. All other trademarks are owned by their respective owners.